Review article
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha
, Katarzyna Krawczyk
Autor para correspondência
sachatom@gmail.com
Corresponding author at: Department of Hematology, Jagiellonian University Medical College, ul. Kopernika 17, 31-501 Kraków, Poland.
Corresponding author at: Department of Hematology, Jagiellonian University Medical College, ul. Kopernika 17, 31-501 Kraków, Poland.
Jagiellonian University Medical College, Kopernika, Kraków, Poland
Lido
4803
Vezesque se leu este artigo
670
Total PDF
4133
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 12 | 444 | 87 | 531 |
| 2025 11 | 577 | 61 | 638 |
| 2025 10 | 501 | 65 | 566 |
| 2025 9 | 667 | 45 | 712 |
| 2025 8 | 318 | 25 | 343 |
| 2025 7 | 181 | 35 | 216 |
| 2025 6 | 112 | 18 | 130 |
| 2025 5 | 183 | 27 | 210 |
| 2025 4 | 316 | 53 | 369 |
| 2025 3 | 147 | 39 | 186 |
| 2025 2 | 112 | 29 | 141 |
| 2025 1 | 126 | 34 | 160 |
| 2024 12 | 135 | 39 | 174 |
| 2024 11 | 123 | 24 | 147 |
| 2024 10 | 87 | 29 | 116 |
| 2024 9 | 50 | 16 | 66 |
| 2024 8 | 54 | 44 | 98 |
Mostrar tudo
